期刊文献+

恶性肿瘤患者糖代谢异常的研究进展 被引量:2

The research advance in malignant tumor patients with glycometabolism disorder
下载PDF
导出
摘要 肿瘤细胞的糖代谢异常普遍地存在于多数肿瘤疾病中,糖酵解途径增强是肿瘤细胞物质代谢中最主要的特点,但随着分子生物学的发展及基因转染技术的兴起,这一理论出现了一些新观点和进展。本文着重就肿瘤细胞糖代谢的特点、机制、糖代谢异常与肿瘤的发生及其他营养物质代谢混乱关系的最新研究成果做一综述,并总结近年来肿瘤代谢的治疗情况。 The glycometabolism disorder is commonly seen in many types of tumor cells. Increasing glycolytic pathmay is the major characteristic in substance metabolism of tumor cells. However, with development of molecular biology and rise of gene transfection technology,new ideas and progress appeared.Our study focused on reviewing the recent development of characteristic and mechanisms in tumor cell glycometabolism. And it also paid attention to the recent studies on the relationship between glycometabolism and other nutrition metabolism disorder. Finally,the related works on therapy were summarized according to the recent research for tumor metabolism.
出处 《微创医学》 2014年第5期604-608,共5页 Journal of Minimally Invasive Medicine
基金 广西科学研究与技术开发计划(合同号:桂科攻1140003A-35)
关键词 恶性肿瘤 糖代谢异常 综述 Malignant tumor Glycometabolism disorder Review
  • 相关文献

参考文献43

  • 1Mullen AR,Wheaton WW,Jin ES,et al.Reductive carboxylation supports growth in tumour cells with defective mitochondria [J].Nature,2012,481(7381):385-388.
  • 2Hsu PP,Sabatini DM.Cancer cell metabolism:Warburg and beyond [J].Cell,2008,134(5):703-707.
  • 3Perkins ND.The diverse and complex roles of NF k B subunits in cancer[J].Nat Rev Cancer,2012,12(2):121-132.
  • 4RodriguezEnriquez S,CarrenoFuentes L,GallardoPerez JC,et al.Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma[J].Int J Biochem cell Biol ,2010,42(10):1744-1751.
  • 5Xu RH,Pelicano H,Zhou Y,et al.Inhibition of glycolysis in cancer cells:a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia[J].Cancer Res,2005,65(2):613-621.
  • 6MorenoSánchez R,RodríguezEnríquez S,MarínHernández A,et al.Energy metabolism in tumor cells [J].2007,274(6):1393-1418.
  • 7Yeung SJ,Pan J,Lee MH.Roles of p53, MYC and HIF 1 in regulating glycolysisthe seventh hallmark of cancer[J].Cellular and Molecular Life Sciences,2008,65(24):3981-3999.
  • 8Demaria M,Giorgi C,Lebiedzinska M,et al.A STAT3 mediated metabolic switch is involved in tumour transformation and STAT3 addiction [J].Aging(Albany NY),2010,2(11):823-842.
  • 9Poon E,Harris AL,Ashcroft M.Targeting the hypoxia inducible factor (HIF) pathway in cancer[J].Expert Rev Mol Med ,2009,11:e26.
  • 10Düvel K,Yecies JL.Menon S,et al.Activation of a metabolic gene regulatory network downstream of mTOR complex 1 [J].Mol Cell ,2010,39(2):171-183.

二级参考文献22

  • 1Herrero-Martin G, Hoyer-Hansen M, Garcia-Garcia C, Fumarola C, Farkas T, Ldpez-Rivas A, et al.TAK1 activates AMPK- dependent cytoprotective autophagy in TRAIL-treated epithelial cells. EMBO J 2009; 28(6): 677-85.
  • 2Pedersen PL, Mathupala S, Rempel A, Geschwind JF, Ko YH. Mitochondrial bound type II hexokinase: A key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta 2002; 1555(1/2/3): 14-20.
  • 3Mathupala SP, Ko YH, Pedersen PL. Hexokinase-2 bound to mitochondria: Cancer's stygian link to the "Warburg effect" and a pivotal target for effective therapy. Semin Cancer Biol 2009; 19(1): 17-24.
  • 4Zhou M, Zhao Y, Ding Y, Liu H, Liu Z, Fodstad O, et al. Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A resensitizes taxol-resistant cancer cells to taxol. Mol Cancer 2010; 9: 33.
  • 5Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA 2010; 107(5): 2037-42.
  • 6Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144(5): 646-74.
  • 7Gatenby RA, Gillies RJ. A microenvironmental model of carcinogenesis. Nat Rev Cancer 2008; 8(1): 56-61.
  • 8Feron O. Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncol 2009; 92(3): 329-33.
  • 9Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452(7184): 230-3.
  • 10David C J, Chen M, Assanah M, Canoll P, Manley JL. HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 2010; 463(7279): 364-8.

共引文献13

同被引文献13

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部